Published May 2020

Opposition case studies

With an increasing number of European patents being granted year on year, freedom to operate for third parties has never been so important. When a patent application is filed at the European Patent Office (EPO), upon grant it becomes a bundle of national patents and subject to national patent laws. For third parties looking to clear the way, this can prove very complicated. Different countries may have differences in national laws and invalidation procedures which may lead to different outcomes.

The EPO offers an efficient and cost effective post grant opposition procedure, whereby within nine months of grant a third party can centrally challenge the European patent. If successful, the patent is then revoked (or amended) across all countries in which it is in force. Oppositions can therefore avoid the potential inconsistency of challenging patents nationally and at a fraction of the price. The official fee for filing an EPO opposition is currently 815 EUR, with attorney fees typically in the tens of thousands of EUR, as opposed to hundreds of thousands or even millions for national litigation.

The statistics on opposition outcomes at the EPO are also generally favourable to the challenger, with just over two thirds of patents opposed either being revoked or amended.

A further advantage of the system is that there is no litigation estoppel. Oppositions can also be filed in the name of a strawman, which is potentially commercially significant. For example the European patent attorney filing the opposition or even another company, to conceal the true identity of the opponent.

Early Certainty From EPO Oppositions

Oppositions at the EPO have a very well-established procedure.

  • Response – After the opposition nine-month filing window ends, a deadline is then set for the patentee to file a response to any oppositions filed.
  • Summons to Oral Proceedings – This includes a non-binding preliminary opinion of the Opposition Division (a panel of three EPO members). This sets a deadline for patentee and opponent(s) to file final written submissions. Typically this might include the patentee filing substitute claim sets (Auxiliary claim sets).
  • Hearing – The Summons also sets the date for an oral hearing for all parties to attend at the EPO in the Hague, Munich or Berlin. It is at this hearing all parties have a final opportunity to plead their case with a decision being announced by the Opposition Division at the end of the hearing. The outcome, which is effective the same day, is either:
    – the patent is revoked; or
    – the opposition is rejected; or
    – the patent is maintained in an amended form, for example on the basis of a substitute claim set.
  • Written Decision – This is then issued within a few months of the hearing, including minutes from the oral hearing.

Following feedback from users of the system, in July 2016 the EPO introduced a streamlined procedure aiming to cut the overall duration of ”straightforward” cases to 15 months from expiry of the opposition filing period (i.e. within two years of grant). This does not involve removing any of the above mentioned steps, but instead the EPO optimising its internal workflows. The mean average duration of opposition proceedings as recently reported for 2019 is just over 18 months.

Opposition timelines

Appeals and Rule Changes

Within two months of the opposition written decision being issued, any party adversely affected can appeal. Procedurally, an appeal follows a similar route to oppositions. It typically culminates in an oral hearing held at the EPO Board of Appeal premises in Haar, Germany. The statistics show that appeals are also relatively successful with half or even more opposition decisions being altered as a result.

Appeal proceedings, however, on average have a longer duration compared to oppositions – almost twice the length. In order to address this and provide more consistency, the Rules of the Boards of Appeal were updated effective 1 January 2020. As well as introducing a number of procedural efficiencies, the changes relate to restricting the appeal to the contents of the opposition. This makes it more difficult to introduce new arguments or documents which were not part of the opposition proceedings.

Conclusion

The EPO opposition procedure is undoubtedly a hugely valuable tool for third parties seeking freedom to operate within Europe. Cost-effective, consistent and time-efficient. In the light of oppositions speeding up and the recent change to the appeal rules, challengers should aim to put their best case forward from the outset.

This article was prepared by HGF Partners Leythem Wall and Mike Nelson. If you would like further advice on this or any other matter, please contact Leythem or Mike.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Read article
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article
Event - 28th October 2026

HGF Attending the KINPA Conference 2026

HGF is pleased to be attending the KINPA Conference 2026, taking place on 28 October in Seoul, South Korea. Recognised as Korea’s largest intellectual property gathering, the conference brings together …

Event details
Event - 17th - 19th November 2026

HGF Attending IPBC Asia 2026

HGF is pleased to announce that Partner, Dr Jennifer Uno, will be attending IPBC Asia 2026, taking place from 17-19 November 2026 in Tokyo, Japan. The event is one of …

Event details

HGF Recognised in the Chambers and Partners UK 2027 Guide

HGF is proud to announce that we have once again been recognised in the Chambers and Partners UK 2027 Guide, with outstanding rankings for both the firm and individual practitioners …

Read article
Event - 4th November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Event details